We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-19.67%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.74B
AUM Growth
-$52.2M
Cap. Flow
+$616M
Cap. Flow %
22.46%
Top 10 Hldgs %
20.88%
Holding
327
New
27
Increased
203
Reduced
54
Closed
34

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$28.8M
2
WW
WW International
WW
+$26.6M
3
WIX icon
WIX.com
WIX
+$21.1M
4
PINC
Premier
PINC
+$20.4M
5
URBN icon
Urban Outfitters
URBN
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 22.84%
2 Industrials 19.01%
3 Technology 16.97%
4 Consumer Discretionary 11%
5 Communication Services 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.A icon
276
Berkshire Hathaway Class A
BRK.A
$1.12T
$306K 0.01%
1
CODA icon
277
Coda Octopus Group
CODA
$120M
$304K 0.01%
52,194
+33,004
+172% +$197K
T icon
278
AT&T
T
$163B
$304K 0.01%
14,124
LLY icon
279
Eli Lilly
LLY
$1.06T
$288K 0.01%
2,490
NOV icon
280
NOV
NOV
$7B
$285K 0.01%
11,082
+456
+4% +$15.8K
WDFC icon
281
WD-40
WDFC
$3.15B
$284K 0.01%
1,550
-100
-6% -$16.9K
AAPL icon
282
Apple
AAPL
$4.57T
$283K 0.01%
7,168
+3,568
+99% +$173K
DENN
283
DELISTED
Denny's
DENN
$278K 0.01%
17,142
+3,000
+21% +$47.2K
OKE icon
284
Oneok
OKE
$54.5B
$270K 0.01%
5,000
BMY icon
285
Bristol-Myers Squibb
BMY
$132B
$240K 0.01%
4,608
XEL icon
286
Xcel Energy
XEL
$48.8B
$240K 0.01%
4,871
HURN icon
287
Huron Consulting
HURN
$2.42B
$223K 0.01%
+4,341
New +$221K
TPIC
288
DELISTED
TPI Composites
TPIC
$223K 0.01%
9,086
-55,110
-86% -$1.4M
JPM icon
289
JPMorgan Chase
JPM
$950B
$220K 0.01%
2,249
+191
+9% +$20.4K
MMM icon
290
3M
MMM
$94.3B
$210K 0.01%
1,317
+120
+10% +$19.9K
ADMS
291
DELISTED
Adamas Pharmaceuticals
ADMS
$196K 0.01%
22,928
+5,810
+34% +$75.6K
AMRS
292
DELISTED
Amyris Inc.
AMRS
$166K 0.01%
+49,620
New +$286K
SPWH icon
293
Sportsman's Warehouse
SPWH
$46M
$86K ﹤0.01%
19,694
+7,142
+57% +$34.7K
AC
294
DELISTED
Associated Capital Group
AC
-38,129
Closed -$1.61M
ASUR icon
295
Asure Software
ASUR
$250M
-95,652
Closed -$1.19M
BP icon
296
BP
BP
$107B
-4,834
Closed -$213K
CHKP icon
297
Check Point Software Technologies
CHKP
$13.1B
-9,421
Closed -$1.11M
CNDT icon
298
Conduent
CNDT
$264M
-1,113,031
Closed -$25.1M
DNOW icon
299
DNOW Inc
DNOW
$2.99B
-1,130,050
Closed -$18.7M
GNTX icon
300
Gentex
GNTX
$5.07B
-94,175
Closed -$2.02M

Similar funds

Rice Hall James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Rice Hall James & Associates held 327 positions worth $2.74B, down 1.9% from $2.79B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Rice Hall James & Associates deployed $616M of net new capital in Q4 2018, opening 27 new positions and adding to 203 existing holdings. Its largest new stake was Myriad Genetics: 800,553 shares worth $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Coherent, an estimated $12.2M trimmed.

  • Rice Hall James & Associates's largest Q4 2018 buy was Myriad Genetics: 800,553 shares worth $23.3M.
  • Rice Hall James & Associates added most to WW International in Q4 2018, an estimated $26.6M increase.
  • Rice Hall James & Associates's biggest Q4 2018 reduction was Coherent, cutting an estimated $12.2M.
  • Rice Hall James & Associates fully exited Conduent in Q4 2018, selling an estimated $25.1M.
  • Rice Hall James & Associates's ten largest holdings make up 21% of its $2.74B portfolio in Q4 2018.
  • Rice Hall James & Associates opened 27 new positions and closed 34 in Q4 2018.
  • Rice Hall James & Associates's portfolio value fell 1.9% quarter-over-quarter to $2.74B.

Based on Rice Hall James & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.